Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences

• 作者: Bin Li Jing-Yuan Tian Lu Zhang
• 来源期刊: 神经免疫与神经炎症（英文版）
• 年，卷（期）: 2019,（5）
• 所属期刊栏目: Review
• 页码范围: 1-16
• 页数: 16页
• 语种: 英文
• DOI: 10.20517/2347-8659.2019.06

摘要

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are autoimmune demyelinating diseases of the central nervous system. Neuromyelitis optica was considered a variant of MS until the discovery of NMO-IgG in 2004, which changed our understanding of the pathophysiology of NMOSD. This review focuses on the similarities and differences in the immune treatments of MS and NMOSD.